Annexon Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts here at Needham & Company. It's my pleasure to introduce our next presenting company Annexon Biosciences.
Joining us today from Annexon is CEO, Doug Love. (Operator Instructions) So that we'll get started. Doug, thank you so much for joining us today.
Thank you, Joey. I appreciate being here. An opportunity to talk to Needham and the folks listening in.
Questions & Answers
Fantastic. Doug, earlier this year Annexon announced a pipeline prioritization program. Can you give us a broad overview of what the updated Annexon pipeline is, and what is your vision going forward?
Yeah, happy to do so. So as you know, Joey, Annexon is
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |